跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,116 条关于
“Sareum Holdings PLC”
全部
7,116
临床试验
3,260
药物
674
机构
1,886
资讯
1,296
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
11个月前
Sareum Halts SDC-1801 Toxicology Study Due to Animal Welfare Concerns, Phase 2 Psoriasis Trial Delayed
2个月前
Sareum Completes Dosing in Phase 2-Enabling Toxicology Programme for TYK2/JAK1 Inhibitor SDC-1801
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
Sareum Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Penetrating TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
去年
COMPASS Pathways Reports Financials and Progress on COMP360 Psilocybin Program
去年
Tezspire Meets Primary Endpoints in WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
第 1 页,共 130 页
上一页
下一页